-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Azelastine-13C-d3
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/azelastine-13c-d3.gif)
| Category | SARS-CoV |
| Description | Azelastine-13C,d3 is deuterium labeled Azelastine. Azelastine, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2. |
Product Information
| Synonyms | Azelastine-13C,d3|758637-88-6|4-[(4-Chlorophenyl)methyl]-2-[hexahydro-1-(methyl-13C,d3)-1H-azepin-4-yl]-1(2H)-phthalazinone |
| Molecular Weight | 385.91 |
| Molecular Formula | C22H24ClN3O |
| Purity | ≥99% deuterated forms (d1-d3) |
| Solubility | DMSO: soluble Methanol: soluble |
| Appearance | Solid |
| Storage | -20°C, sealed |
| Exact Mass | 401.17800 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| PSA | 64.32000 |
| Target | Histamine Receptor; SARS-CoV |
